neuromuscular electrical stimulation in icu patients

Conditions: Intensive Care Unit Acquired Weakness

Summary: the aim of the present study is to evaluate the effects of neuromuscular electrical stimulation (nmes) combined with conventional physiotherapy (experimental group), compared to conventional physiotherapy only (control group) in critically ill intensive care unit (icu) patients, by means of a randomized controlled clinical trial. the investigators expect that the nmes program will be able to reduce muscle structure and function losses compared to control group, and will improve muscle quality faster, will reduce the ventilation time and the total time spent at the icu, as well as improve functionality of these patients. in addition, the researchers expect to understand which mechanisms determine such adaptations in the musculoskeletal system of these patients.

the aim of the present study is to evaluate the effects of neuromuscular electrical stimulation (nmes) combined with conventional physiotherapy (experimental group), compared to conventional physiotherapy only (control group) in critically ill icu patients, by means of a randomized controlled clinical trial. primary outcomes evaluated during icu patient's hospitalization are (1) the time spent in the icu; (2) time of mechanical ventilation; (3) time and success of weaning (up to 48 hours), (4) the isometric torque from contractions artificially generated by nmes and evaluated by dynamometry; (5) muscle morphology and quality by means of ultrasonography. secondary outcomes include (6) the sit and stand test; (7) gait speed test; (8) autonomic control (heart rate variability); (9) peripheral polyneuropathy by means of mrc scale; (10) inflammatory profile - inflammatory (il-6 and tnf-α) and anti-inflammatory (il-10) cytokines; (11) blood muscular biochemical markers (igf1, ldh, ck); (12) predictive mortality index for patients admitted to the icu (saps 3); (13) survival rate; and (14) mobility (perme). after discharge from the icu or as soon as the patients are able to perform force voluntarily, the maximum voluntary torque will also be evaluated by means of dynamometry. also, clinical data, hemodynamic variables, dosage of neuromuscular blockers and corticosteroids, blood glucose levels in the morning, daily water balance, oxygenation index, arterial blood gases, mechanical ventilator parameters, glasgow scale, sedation scale (rass), will be recorded daily. the investigators expect that the nmes program will be able to reduce muscle structure and function losses compared to control group, and will improve muscle quality, will reduce the ventilation time and the total time spent at the icu, as well as improve functionality of these patients. in addition, the researchers expect to understand which mechanisms determine such adaptations in the musculoskeletal system of these patients.

Eligibility criteria:
inclusion criteria: * patients with any clinical condition hospitalized in the icu, which are monitored by the physiotherapy service: * cerebrovascular diseases * other bacterial diseases * circulatory and respiratory diseases * digestive and abdominal diseases * liver diseases * time between the patient's icu entry and the onset of the nmes intervention less than one week. patients may be in mechanical ventilation, non-invasive ventilation, oxygen therapy or oxygen ambient ventilation (no ventilatory add). patients re-admitted to the icu within the same hospitalization period (i.e., did not leave the hospital) may also be included, as well as patients with previous tracheostomy. exclusion criteria: * previously diagnosed neuromuscular diseases: * als * guillain barre * chronic stroke * trm * end-stage malignant disease * lower limbs' amputation * body mass index above 40 kg/m2 * cachexia (defined as the presence of chronic disease and weight loss ≥ 5% in a period shorter than 12 months or bmi \< 20 kg/m2, associated with at least three of the following criteria: (1) decreased muscle strength; (2) fatigue; (3) anorexia; (4) reduction of fat free mass index; and (5) biochemical abnormalities such as inflammation, anemia or reduction of serum albumin concentration). * lesions on the skin at the electrode placement and/or dynamometer support points * post-operative transplantation * patients using a neuromuscular blocker * hemodynamic instability (nora \> 10; abcde criteria) * height \< 1.50m * rhabdomyolysis